ATS Reports Second Quarter Fiscal 2025 Results

In This Article:

CAMBRIDGE, Ontario, November 06, 2024--(BUSINESS WIRE)--ATS Corporation (TSX and NYSE: ATS) ("ATS" or the "Company") today reported its financial results for the three and six months ended September 29, 2024. All references to "$" or "dollars" in this news release are to Canadian dollars unless otherwise indicated.

Second quarter highlights:

  • Revenues decreased 16.7% year over year to $612.8 million.

  • Net loss was $0.9 million compared to net income of $50.7 million a year ago.

  • Basic earnings (loss) per share were (1) cent, compared to 51 cents a year ago.

  • Adjusted EBITDA1 was $78.3 million compared to $116.2 million a year ago.

  • Adjusted basic earnings per share1 were 25 cents compared to 63 cents a year ago.

  • Order Bookings2 were $742 million, flat year over year.

  • Order Backlog2 was $1,824 million at the end of the quarter.

"Today ATS reported second quarter results for fiscal '25. Financial results were mixed, given lower transportation revenues, offset by solid execution across the majority of our businesses, most notably in life sciences where we are driving profitable growth both organically and through acquisition. We also had the highest quarterly bookings in company history for our life sciences business," said Andrew Hider, Chief Executive Officer. "As expected, overall revenues were lower as a result of the anticipated reduction in transportation revenues due to shifting customer investment trends in North American electric vehicle production. As planned, we took action to lower our cost structure to address this market dynamic."

The Company also provided an update on its large electric vehicle ("EV") projects (see "Update on Large EV Customer Projects").

Year-to-date highlights:

  • Revenues decreased 12.2% year over year to $1,307.1 million.

  • Net Income decreased 65.1% year over year to $34.4 million.

  • Basic earnings per share decreased 65.7% year over year to $0.35.

  • Adjusted EBITDA1 decreased 21.7% year over year to $184.3 million.

  • Adjusted basic earnings per share1 decreased 43.2% year over year to $0.75.

  • Order Bookings1 were $1,559 million, compared to $1,432 million a year ago.

Mr. Hider added: "During the quarter, we completed the acquisitions of Paxiom and Heidolph, further diversifying our offerings across market verticals. Our teams remain focused on disciplined execution of strategy for value creation, supported by our ABM."

1 Non-IFRS measure: see "Notice to Reader: Non-IFRS and Other Financial Measures".

2 Supplementary financial measure: see "Notice to Reader: Non-IFRS and Other Financial Measures".

Financial results

(In millions of dollars, except per share and margin data)

 

 

Three Months

Ended

September 29,

2024

 

Three Months

Ended

October 1, 2023

 

 

Variance

Six Months

Ended

September 29,

2024

 

Six Months

Ended

October 1, 2023

 

 

Variance

Revenues

$

612.8

$

735.7

(16.7)%

$

1,307.1

$

1,489.4

(12.2)%

Net income (loss)

$

(0.9)

$

50.7

(101.8)%

$

34.4

$

98.5

(65.1)%

Adjusted earnings from operations1

$

56.5

$

98.3

(42.5)%

$

142.6

$

200.4

(28.8)%

Adjusted earnings from operations margin2

 

9.2%

 

13.4%

(414)bps

 

10.9%

 

13.5%

(255)bps

Adjusted EBITDA1

$

78.3

$

116.2

(32.6)%

$

184.3

$

235.4

(21.7)%

Adjusted EBITDA margin2

 

12.8%

 

15.8%

(302)bps

 

14.1%

 

15.8%

(171)bps

Basic earnings (loss) per share

$

(0.01)

$

0.51

(102.0)%

$

0.35

$

1.02

(65.7)%

Adjusted basic earnings per share1

$

0.25

$

0.63

(60.3)%

$

0.75

$

1.32

(43.2)%

Order Bookings3

$

742

$

742

—%

$

1,559

$

1,432

8.9%

As At

September 29

2024

October 1

2023

Variance

Order Backlog3

$

1,824

$

2,016

(9.5)%

1 Non-IFRS financial measure - See "Non-IFRS and Other Financial Measures."

2 Non-IFRS ratio - See "Non-IFRS and Other Financial Measures."

3 Supplementary financial measure - See "Non-IFRS and Other Financial Measures."

Recent Acquisitions

On July 24, 2024, the Company acquired Paxiom Group ("Paxiom"). With headquarters in Montreal, Canada, Paxiom is a provider of primary, secondary, and end-of-line packaging machines in the food and beverage, cannabis, and pharmaceutical industries. Paxiom's product line is expected to complement ATS’ packaging and food technology businesses and allow ATS to offer complete packaging and end-of-line solutions. The total purchase price paid in the second quarter of fiscal 2025 was $148.7 million.